MX2021002719A - Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos. - Google Patents

Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos.

Info

Publication number
MX2021002719A
MX2021002719A MX2021002719A MX2021002719A MX2021002719A MX 2021002719 A MX2021002719 A MX 2021002719A MX 2021002719 A MX2021002719 A MX 2021002719A MX 2021002719 A MX2021002719 A MX 2021002719A MX 2021002719 A MX2021002719 A MX 2021002719A
Authority
MX
Mexico
Prior art keywords
cannabinoids
gram
treatment
bacterial strains
resistant bacterial
Prior art date
Application number
MX2021002719A
Other languages
English (en)
Inventor
Brian Murphy
Mahmoud Elsohly
Waseem Gul
Melissa Jacob
Original Assignee
Nemus Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nemus Bioscience Inc filed Critical Nemus Bioscience Inc
Publication of MX2021002719A publication Critical patent/MX2021002719A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención proporciona composiciones y métodos para tratar o prevenir una infección bacteriana grampositiva. En un aspecto, la composición comprende por lo menos dos cannabinoides.
MX2021002719A 2018-09-05 2019-09-05 Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos. MX2021002719A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862727460P 2018-09-05 2018-09-05
PCT/US2019/049671 WO2020051284A1 (en) 2018-09-05 2019-09-05 Cannabinoids for the treatment of gram-positive infections including antibiotic-resistant bacterial strains

Publications (1)

Publication Number Publication Date
MX2021002719A true MX2021002719A (es) 2021-09-23

Family

ID=69722728

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021002719A MX2021002719A (es) 2018-09-05 2019-09-05 Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos.

Country Status (5)

Country Link
US (1) US20210315837A1 (es)
EP (1) EP3846616A4 (es)
CA (1) CA3111979A1 (es)
MX (1) MX2021002719A (es)
WO (1) WO2020051284A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021521277A (ja) 2018-04-09 2021-08-26 エレヴェット・サイエンシズ 動物における疼痛の処置のためのアサ抽出物
KR20220005066A (ko) * 2019-05-06 2022-01-12 더 유니버시티 오브 브리티쉬 콜롬비아 항생제 칸나비노이드-테르펜 제형
US20220296535A1 (en) * 2019-06-18 2022-09-22 Botanix Pharmaceuticals Limited Antibacterial Dosage Regime Using Cannabinoids
WO2022165439A1 (en) * 2021-02-01 2022-08-04 Aion Therapeutic Inc. Methods for treatment of human cancers using cannabis compositions
WO2022180068A1 (en) * 2021-02-23 2022-09-01 Pharmotech Sa Biocide compositions and uses thereof
EP4363411A1 (en) * 2021-07-01 2024-05-08 University of Mississippi Cannabichromene derivatives and methods for making and using the same
WO2023177452A1 (en) * 2022-03-14 2023-09-21 Colorado Chromatography, Llc Hydrogenation of cannabigerol and cannabichromene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1559423A1 (en) * 2004-02-02 2005-08-03 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Medicinal acidic cannabinoids
US9192598B2 (en) * 2008-06-25 2015-11-24 University Of North Texas Health Science Center At Fort Worth Prevention of bacterial growth and biofilm formation by ligands that act on cannabinoidergic systems
WO2016044370A1 (en) * 2014-09-16 2016-03-24 India Globalization Capital, Inc. Cannabinoid composition and method for treating pain
US20160374958A1 (en) * 2015-06-23 2016-12-29 Axim Biotechnologies, Inc. Anti-microbial composition comprising cannabinoids
EP3452036A4 (en) * 2016-05-04 2019-11-06 Inmed Pharmaceuticals Inc. USE OF TOPICAL FORMULATIONS OF CANNABINOIDS FOR THE TREATMENT OF BLEED EPIDERMOLYSIS AND RELATED CONNECTIVE TISSUE DISORDERS
EP3251668A1 (en) * 2016-06-02 2017-12-06 Pharmotech SA Cannabidiol compositions and uses thereof
CN109562094A (zh) * 2016-07-14 2019-04-02 希拉匹克斯生物科学有限公司 增强抗微生物剂的组合物和方法

Also Published As

Publication number Publication date
WO2020051284A1 (en) 2020-03-12
CA3111979A1 (en) 2020-03-12
EP3846616A4 (en) 2022-05-25
US20210315837A1 (en) 2021-10-14
EP3846616A1 (en) 2021-07-14

Similar Documents

Publication Publication Date Title
MX2021002719A (es) Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos.
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
NZ742787A (en) Compositions comprising bacterial strains
MX2019007613A (es) Terapia de combinacion con compuestos ?-lactamicos sustituidos con amidina e inhibidores de ?-lactamasa para infecciones con cepas bacterianas resistentes a antibioticos.
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
WO2018208987A3 (en) Antibacterial compounds
PH12019500360A1 (en) Antibiotic compounds
MX2021003084A (es) Compuestos antibacterianos.
MX2020006191A (es) Bacteriocinas terapeuticas.
ZA202002093B (en) Antibacterial compounds
ZA202006612B (en) Antibacterial compounds
MX2017012535A (es) Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
MX2017012073A (es) Compuestos de minociclina para biodefensas.
WO2020102901A8 (en) Synthetic antibacterial compounds and uses thereof
MX2019015007A (es) Composiciones inmunogénicas que comprenden los polipéptidos derivados de la leucocidina de staphylococcus aureus luka y lukb.
MX2017014080A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
MX2018001512A (es) Composiciones antimicrobianas que comprenden mupirocina y neomicina.
EP4132539A4 (en) COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS
MX2022003871A (es) Composiciones inmunogénicas.
MX2018011095A (es) Compuestos de carbapenem.
MX2017012539A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
MX2017015988A (es) Derivados de manosa para tratar infecciones bacterianas.
PH12019502915A1 (en) Immunogenic compositions
MX2020012543A (es) Diltiazem para usarse en el tratamiento de infecciones microbianas.
MX2019006086A (es) Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados.